The age of precision wellness has arrived. Plant-based diets, post-pandemic immune awareness, and the rising incidence of metabolic syndrome among younger populations are converging to transform the functional food market — shifting consumer expectations from general supplementation to targeted, science-backed health solutions. Digestive discomfort, blood sugar spikes, poor sleep, and chronic allergies are no longer quietly tolerated; they are the entry points where brands can build real loyalty. Yet the market isn't short of ingredients — what brands genuinely lack is a partner who can explain the mechanism, tell a credible origin story, and back it all up with data. That is the proposition M.H. Biotechnology brings to Asia Expo Taiwan 2026.

M.H. Biotech's three patented plant extracts each address a distinct and high-growth wellness category. HWESS® Wax Apple Extract has demonstrated stronger postprandial blood glucose control than commercially available bitter melon peptides, with a human trial showing weight reduction and a trend toward improved HbA1c — giving this locally-grown Taiwan ingredient a credible foothold in metabolic health and weight management formulations. EDFF® Dragon Fruit Flower Extract, rich in dietary fiber, functional amino acids, and PQQ, outperformed inulin in promoting beneficial gut bacteria in animal studies, while also showing potential for fatigue relief and sleep support — a versatile ingredient across sports health and digestive wellness categories. HWEGC® Red Algae Extract continues to build its immunology credentials, with data showing a 75% reduction in nasal allergy frequency after 30 days of intake, as well as cell study support for protection against PM2.5-induced pulmonary inflammation and H1N1 viral infection — a strong scientific foundation for respiratory health and post-illness recovery applications.

Beyond its proprietary extracts, M.H. Biotech has also launched the Tempeh Protein Powder Series this year, fermenting four bean varieties — soy, black bean, chickpea, and multi-bean — using a patented Taiwanese Rhizopus microsporus strain to offer brands a differentiated plant protein ingredient option. The fermentation process converts isoflavones into highly bioavailable aglycone forms while naturally generating vitamin B₁₂, a nutrient critically lacking in vegan diets. The series holds Japan VegeProject Vegan certification and is suitable for a wide range of applications including health capsules, functional beverages, and baked goods. 

From blood glucose management to immune regulation, from gut health to plant protein bioavailability, M.H. Biotechnology aspires to be more than an ingredient supplier — it aims to be the most reliable formulation partner brands can turn to when building their presence in the precision wellness market. With full OEM/ODM service capabilities spanning ingredient selection, formula development, and finished product delivery, M.H. Biotech accompanies brands every step of the way, from concept to launch.